JP2017533197A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533197A5 JP2017533197A5 JP2017521096A JP2017521096A JP2017533197A5 JP 2017533197 A5 JP2017533197 A5 JP 2017533197A5 JP 2017521096 A JP2017521096 A JP 2017521096A JP 2017521096 A JP2017521096 A JP 2017521096A JP 2017533197 A5 JP2017533197 A5 JP 2017533197A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- strain
- stopband
- composition according
- culture collection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 22
- 238000011534 incubation Methods 0.000 claims 6
- 244000005700 microbiome Species 0.000 claims 6
- 230000035899 viability Effects 0.000 claims 4
- 241000588724 Escherichia coli Species 0.000 claims 3
- 241000607142 Salmonella Species 0.000 claims 3
- 241000191967 Staphylococcus aureus Species 0.000 claims 3
- 230000000844 anti-bacterial effect Effects 0.000 claims 3
- 230000005764 inhibitory process Effects 0.000 claims 3
- 241000193798 Aerococcus Species 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 241000194033 Enterococcus Species 0.000 claims 2
- 241000186660 Lactobacillus Species 0.000 claims 2
- 241000194036 Lactococcus Species 0.000 claims 2
- 241000192132 Leuconostoc Species 0.000 claims 2
- 241000186781 Listeria Species 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 241000202223 Oenococcus Species 0.000 claims 2
- 241000192001 Pediococcus Species 0.000 claims 2
- 241000204117 Sporolactobacillus Species 0.000 claims 2
- 241000194017 Streptococcus Species 0.000 claims 2
- 241000500334 Tetragenococcus Species 0.000 claims 2
- 241000207194 Vagococcus Species 0.000 claims 2
- 208000036142 Viral infection Diseases 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 210000000941 bile Anatomy 0.000 claims 2
- 229940039696 lactobacillus Drugs 0.000 claims 2
- 230000000813 microbial effect Effects 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 241000206594 Carnobacterium Species 0.000 claims 1
- 241000186840 Lactobacillus fermentum Species 0.000 claims 1
- 241000394636 Lactobacillus mucosae Species 0.000 claims 1
- 240000006024 Lactobacillus plantarum Species 0.000 claims 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims 1
- 241000186604 Lactobacillus reuteri Species 0.000 claims 1
- 241000186779 Listeria monocytogenes Species 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 230000001332 colony forming effect Effects 0.000 claims 1
- 229940012969 lactobacillus fermentum Drugs 0.000 claims 1
- 229940072205 lactobacillus plantarum Drugs 0.000 claims 1
- 229940001882 lactobacillus reuteri Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14382412.6 | 2014-10-21 | ||
| EP14382412 | 2014-10-21 | ||
| PCT/EP2015/074375 WO2016062771A1 (en) | 2014-10-21 | 2015-10-21 | Probiotic and prebiotic compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017533197A JP2017533197A (ja) | 2017-11-09 |
| JP2017533197A5 true JP2017533197A5 (cg-RX-API-DMAC7.html) | 2018-12-06 |
| JP6765370B2 JP6765370B2 (ja) | 2020-10-07 |
Family
ID=51846603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017521096A Active JP6765370B2 (ja) | 2014-10-21 | 2015-10-21 | プロバイオティクス組成物及びプレバイオティクス組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10179153B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3209307B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6765370B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102517581B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107073049B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015334989B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112017008184B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2965214C (cg-RX-API-DMAC7.html) |
| DK (1) | DK3209307T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2936842T3 (cg-RX-API-DMAC7.html) |
| PH (1) | PH12017500708A1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL3209307T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2741836C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016062771A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10624934B2 (en) | 2014-03-06 | 2020-04-21 | Research Institute At Nationwide Children's Hospital | Prebiotic formulations |
| JP6754694B2 (ja) * | 2014-03-06 | 2020-09-16 | リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル | プロバイオティクス製剤および使用のための方法 |
| US11959125B2 (en) | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| KR101851297B1 (ko) * | 2017-02-13 | 2018-04-23 | 강원대학교 산학협력단 | 신규한 락토바실러스 루테리 균주 및 그 항균 용도 |
| EP3648769A4 (en) * | 2017-06-30 | 2021-04-07 | The Rockefeller University | N-ACYL AMIDES DERIVED FROM THE HUMAN MICROBIOTE FOR THE TREATMENT OF HUMAN DISEASE |
| KR20190070457A (ko) | 2017-12-13 | 2019-06-21 | 주식회사 오투파워 | 이산화염소를 포함하는 닭 대장균증 예방을 위한 음용수 첨가용 조성물 |
| CN109385387B (zh) * | 2018-12-28 | 2022-04-05 | 上海源耀农牧科技有限公司 | 一种抗tgev的罗伊氏乳杆菌及其应用 |
| JP7662538B2 (ja) | 2019-06-03 | 2025-04-15 | リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル | 敗血症および壊死性腸炎誘発神経発達不全の予防のためのプレバイオティクス製剤 |
| CN112877231B (zh) * | 2019-11-29 | 2023-06-23 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 具有抑菌和抗氧化活性的乳酸菌及其应用 |
| WO2021195577A2 (en) * | 2020-03-26 | 2021-09-30 | Persephone Biosciences, Inc. | Compositions for modulating gut microflora populations, enhancing drug potency and treating viral infections, and methods for making and using same |
| WO2021211620A1 (en) * | 2020-04-13 | 2021-10-21 | Sun Genomics, Inc. | Method and system for detecting and treating exposure to an infectious pathogen |
| CA3186609A1 (en) * | 2020-06-10 | 2021-12-16 | The Board Of Trustees Of The University Of Arkansas | Swine origin probiotics that promote health and growth performance in pigs |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1034788A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactic acid bacteria strains capable of preventing diarrhea |
| US7939061B2 (en) * | 2003-02-28 | 2011-05-10 | Micropharma Limited | Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| WO2005007834A1 (en) * | 2003-07-23 | 2005-01-27 | Probionic Corp. | Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus |
| KR100513168B1 (ko) * | 2003-08-27 | 2005-09-07 | 주식회사 프로바이오닉 | 돼지 유행성 설사증 (PED) 코로나바이러스 및 유해 미생물 억제 활성을 가지는 신규 내 산성 엔테로코커스 훼카리스Probio-056 및 이를 함유하는 생균활성제 |
| EP1997499A1 (en) | 2007-05-31 | 2008-12-03 | Puleva Biotech, S.A. | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis |
| CA2783414A1 (en) * | 2012-07-22 | 2014-01-22 | Integral Medical Inc. | Probiotic composition |
| KR102324015B1 (ko) * | 2012-09-25 | 2021-11-10 | 아퀼론 씨와이엘 에스.엘. | 프로바이오틱 및 프리바이오틱 조성물 |
-
2015
- 2015-10-21 BR BR112017008184-9A patent/BR112017008184B1/pt not_active IP Right Cessation
- 2015-10-21 KR KR1020177013629A patent/KR102517581B1/ko active Active
- 2015-10-21 AU AU2015334989A patent/AU2015334989B2/en active Active
- 2015-10-21 CN CN201580057157.0A patent/CN107073049B/zh active Active
- 2015-10-21 PL PL15784636.1T patent/PL3209307T3/pl unknown
- 2015-10-21 ES ES15784636T patent/ES2936842T3/es active Active
- 2015-10-21 DK DK15784636.1T patent/DK3209307T3/da active
- 2015-10-21 EP EP15784636.1A patent/EP3209307B1/en active Active
- 2015-10-21 WO PCT/EP2015/074375 patent/WO2016062771A1/en not_active Ceased
- 2015-10-21 RU RU2017113027A patent/RU2741836C2/ru active
- 2015-10-21 CA CA2965214A patent/CA2965214C/en active Active
- 2015-10-21 JP JP2017521096A patent/JP6765370B2/ja active Active
- 2015-10-21 US US15/520,622 patent/US10179153B2/en active Active
-
2017
- 2017-04-17 PH PH12017500708A patent/PH12017500708A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017533197A5 (cg-RX-API-DMAC7.html) | ||
| RU2017113027A (ru) | Пробиотические и пребиотические соединения | |
| Sharma et al. | Antibiotic resistance among commercially available probiotics | |
| RU2372788C2 (ru) | Пробиотическая стимулирующая здоровье или производительность кормовая добавка или добавка к питьевой воде, а также ее применение | |
| Georgieva et al. | Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures | |
| Soleimani et al. | Antagonistic activity of probiotic lactobacilli against Staphylococcus aureus isolated from bovine mastitis | |
| Sabia et al. | Detection and partial characterization of a bacteriocin-like substance produced by Lactobacillus fermentum CS57 isolated from human vaginal secretions | |
| PH12015502416A1 (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
| Ceugniez et al. | Anti-Salmonella activity and probiotic trends of Kluyveromyces marxianus S-2-05 and Kluyveromyces lactis S-3-05 isolated from a French cheese, Tomme d'Orchies | |
| RU2018113245A (ru) | Новая лактобактерия, характеризующаяся различными функциями, и ее применение | |
| JP2016522810A5 (cg-RX-API-DMAC7.html) | ||
| Kim et al. | Survival, prophage induction, and invasive properties of lysogenic Salmonella Typhimurium exposed to simulated gastrointestinal conditions | |
| Chen et al. | Impact of enrofloxacin and florfenicol therapy on the spread of OqxAB gene and intestinal microbiota in chickens | |
| Aazami et al. | Characterization of some potentially probiotic Lactobacillus strains isolated from Iranian native chickens | |
| CN113040390B (zh) | 一株益生、耐盐约氏乳杆菌及其在畜禽水产养殖中防治病原菌的应用 | |
| JP2014113137A5 (cg-RX-API-DMAC7.html) | ||
| CN113604387B (zh) | 一株耐盐、耐高温罗伊氏乳杆菌及其在畜禽水产养殖中防治病原菌的应用 | |
| MX2009006808A (es) | Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico. | |
| Borges et al. | Characterization of a bacteriocin of Pediococcus pentosaceus SB83 and its potential for vaginal application | |
| US10166262B2 (en) | Strain of bacteria and composition comprising the same | |
| Park et al. | Antimicrobial effect of lactic acid producing bacteria culture condensate mixture (LCCM) against Salmonella enteritidis | |
| JP2008173050A5 (cg-RX-API-DMAC7.html) | ||
| EP3168292B1 (en) | New lactobacillus plantarum strain amt14 and composition containing the strain of lactobacillus plantarum amt14 | |
| KR20210067274A (ko) | 붉바리 양식용 미생물 제제 | |
| Kugadas et al. | Growth of Mannheimia haemolytica: inhibitory agents and putative mechanism of inhibition |